๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Polycythemia Vera

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms NCT06063486Phase 22 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles University of Southern California ยท Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Curcumin/ Demethoxycurcumin/Bisdemethoxycurcumin-coโ€ฆ Asian Myeloproliferative Neoplasm (MPN) Registry NCT05882773n/a1 site๐Ÿ“ Hong Kong The University of Hong Kong Study of INCA036978 in Participants With Myeloproliferative Neoplasms NCT07441694Phase 154 sites๐Ÿ“ Birmingham๐Ÿ“ Irvine๐Ÿ“ Los Angeles Incyte Corporation ยท Tests: INCA036978, Standard disease-directed therapy MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera NCT04116502Phase 355 sites๐Ÿ“ Aberdeen๐Ÿ“ Bath๐Ÿ“ Belfast University of Birmingham ยท Tests: Ruxolitinib, Hydroxycarbamide, Interferon-Alpha Research Platform Myelofibrosis and Anemia NCT06976918n/a1 site๐Ÿ“ Multiple Locations iOMEDICO AG Myeloproliferative Neoplasms (MPNs) Patient Registry NCT02760238n/a1 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: Observational Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) NCT06327100Phase 1, Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Ruxolitinib, Tasquinimod Effect of Phlebotomy on Heartrate in Polycythemia Patients NCT05396170n/a1 site๐Ÿ“ Leiden Leiden University Medical Center ยท Tests: phlebotomy A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) NCT06661915Phase 231 sites๐Ÿ“ Irvine๐Ÿ“ Orange๐Ÿ“ Palo Alto National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Decitabine and Cedazuridine, Iadademstat Ruxolitinib in Thrombocythemia and Polycythemia Vera NCT04644211Phase 24 sites๐Ÿ“ Boston๐Ÿ“ Boston๐Ÿ“ Boston Massachusetts General Hospital ยท Tests: Ruxolitinib Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients NCT04655092Phase 36 sites๐Ÿ“ Toon-shi๐Ÿ“ Tsu๐Ÿ“ Suita-shi PharmaEssentia Japan K.K. ยท Tests: P1101 (Ropeginterferon alfa-2b) Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly NCT06743035n/a1 site๐Ÿ“ Hanover iOMEDICO AG Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis. NCT05440838n/a6 sites๐Ÿ“ Angers๐Ÿ“ Brest๐Ÿ“ Nantes University Hospital, Angers ยท Tests: Next-generation sequencing Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera NCT06093672Phase 390 sites๐Ÿ“ Birmingham๐Ÿ“ Redlands๐Ÿ“ Englewood Italfarmaco ยท Tests: Givinostat, Hydroxyurea A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025). NCT07722611Phase 2, Phase 32 sites๐Ÿ“ Charlottesville๐Ÿ“ Jerusalem Merck Sharp & Dohme LLC ยท Tests: Bomedemstat, Ruxolitinib, Ropeginterferon alfa-2b Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms NCT04282187Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Decitabine, Ruxolitinib, Fedratinib, Questionnaire Administration, Pacritinib A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera NCT06752746Phase 16 sites๐Ÿ“ Zhengzhou๐Ÿ“ Wuhan๐Ÿ“ Nanchang Mabwell (Shanghai) Bioscience Co., Ltd. ยท Tests: 9MW3011 Therapeutic RSK1 Targeting in Myeloid Malignancies NCT07379125Phase 11 site๐Ÿ“ St Louis Washington University School of Medicine ยท Tests: PMD-026 Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) NCT05835466Phase 29 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Buffalo Icahn School of Medicine at Mount Sinai ยท Tests: reparixin A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i) NCT06343805Phase 121 sites๐Ÿ“ Palo Alto๐Ÿ“ Tampa๐Ÿ“ Kansas City Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lโ€ฆ ยท Tests: LY5830966 Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia NCT05320198Phase 1, Phase 235 sites๐Ÿ“ Gilbert๐Ÿ“ Duarte๐Ÿ“ Irvine Disc Medicine, Inc ยท Tests: DISC-0974 A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes NCT07203768n/a24 sites๐Ÿ“ Rochester๐Ÿ“ Halle๐Ÿ“ Hanover FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial NCT06541249Phase 21 site๐Ÿ“ New York Icahn School of Medicine at Mount Sinai ยท Tests: Methotrexate (MTX) A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis NCT05714072Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Ruxolitinib, Abemaciclib MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225n/a2 sites๐Ÿ“ Chicago๐Ÿ“ New York MPN Research Foundation A Study of GLB-001 in Patients With Myeloid Malignancies NCT06378437Phase 114 sites๐Ÿ“ Hefei๐Ÿ“ Beijing๐Ÿ“ Chongqing Hangzhou GluBio Pharmaceutical Co., Ltd. ยท Tests: GLB-001 MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients With Philadelphia-negative Chronic Myeloproliferative Neoplasms NCT07863466n/a1 site๐Ÿ“ Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico Efficacy and Safety of Peginterferon in ET and PV. NCT06734637NA1 site๐Ÿ“ Wuhan Zhenya Hong ยท Tests: Peginterferon ฮฑ-2b injection AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms NCT05198960Phase 342 sites๐Ÿ“ Angers๐Ÿ“ Annecy๐Ÿ“ Argenteuil University Hospital, Brest ยท Tests: Direct Oral Anticoagulants, Low-dose aspirin Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV) NCT06506084n/a37 sites๐Ÿ“ Bergamo๐Ÿ“ Milan๐Ÿ“ Pavia FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS ยท Tests: Ropeginterferon alfa-2b
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy